Indication intelligence, analysis and sector perception

RegMed/Cell and Gene Therapy Earnings Scorecard Q1/21 LPS Results

June 16, 2021

A scorecard of earnings releases of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status" 32 to date <MESO is added>  

Q2/21 Earnings - (LPS - loss-per-share) Results

June 16, 2021

A scorecard of of 35 covered  companies The current LPS (loss per share) or net income, cash positions i.e. "runways"  is a reflection of this universe's investing "status"

The Biostage (BSTG) Chronicles: Questions continue as RSM US LLP, their auditor “ceased the client-auditor relationship”

May 28, 2021

Wouldn’t quit, walked-away or resigned fit the action specifically Maintaining Sell WHY and WHAT is behind the latest SEC 8-K filing where RSM US LLP (the accounting/audit firm) stated “that the client-auditor relationship between the Company and RSM has ceased. Prior to such notification, RSM had recently served as the Company’s independent auditors through the recent Form 10-Q filing by the Company on May 24, 2021. The change in accountants was NOT recommended by the audit committee of the board of directors.” <read more>